PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million -
PRESS RELEASE
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
Mainz Biomed to present new pooled colorectal cancer screening data at ASCO 2024 Annual Meeting, showcasing significant advancements in early detection and diagnostic performance -
-
PRESS RELEASE
Suralink Wins Gold in 2024 Titan Business Awards and Advances to International Accounting Awards Finals for Above-and-Beyond Customer Service
Suralink wins gold in Titan Business Awards' Customer Service Team of The Year category and is a finalist in International Accounting Awards, showcasing dedication to exceptional client services -
-
PRESS RELEASE
Rehab.com Study Finds Southern States Rank Worst in Nation for Drug Abuse & Addiction
New study ranks five Southern states as worst for drug and alcohol addiction, overdoses, and drug crimes. DEA raises concerns about fentanyl impact. Report details city and state rankings based on data from various sources -
PRESS RELEASE
Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab
Imagene's LungOI AI-based NSCLC Biomarker Profiling Test receives Medicare payment rate, positioning it as a leading LDT product for lung genomic alterations detection
